Dec 28, 2022
Rayne Guest, the Founder and CEO of ArrowClean, raises the alarm about the lack of effectiveness of traditional disinfectants to eliminate superbugs and other contaminants. Some of the most vulnerable people are in hospitals where patients and staff are exposed to germs, many of which are not treatable. ArrowClean is...
Dec 28, 2022
Rayne Guest, the Founder and CEO of ArrowClean, raises the alarm about the lack of effectiveness of traditional disinfectants to eliminate superbugs and other contaminants. Some of the most vulnerable people are in hospitals where patients and staff are exposed to germs, many of which are not treatable. ArrowClean is...
Oct 13, 2021
Dr. Mike Dudley is President and CEO of QpexBiopharma and seeing drug-resistant infections occurring inside the hospital as well as outside the hospital. Qpex is developing IV and oral drugs that are designed to overcome resistance mechanisms in bacteria that render penicillin-like drugs inactive.
Mike explains, "We...
Oct 13, 2021
Dr. Mike Dudley is President and CEO of QpexBiopharma and seeing drug-resistant infections occurring inside the hospital as well as outside the hospital. Qpex is developing IV and oral drugs that are designed to overcome resistance mechanisms in bacteria that render penicillin-like drugs inactive.
Mike explains, "We...
Apr 28, 2021
Ron Chiarello PhD, Founder, CEO and Chairman of the Board, Alveo Technologies talks about the need for a low-cost, easy-to-use diagnostic platform to allow more people to detect and manage an infectious disease like COVID-19. Winning the XPRIZE Rapid COVID-19 Testing Competition has highlighted their be.well diagnostic...